🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was a prospective, open-label, non-controlled, non-randomized multicen...
Status
Completed
Location
University of California Irvine
Start Date
2011-05
Trial ID
NCT01313507
Treatments Being Tested
NewGam is a newly developed human normal immunoglobulin solution for intrav...
Status
Completed
Location
Abdulgabar Salama
Start Date
2011-10
Trial ID
NCT01349790
Treatments Being Tested
Study to evaluate the Efficacy and Safety of Three Different Dosages of New...
Status
Completed
Location
MHAT Puls EOOD
Start Date
2017-09-27
Trial ID
NCT02638207
Treatments Being Tested
The purpose of this study was to determine the efficacy of NewGam in preven...
Status
Completed
Location
Sudir Gupta, MD
Start Date
2010-01
Trial ID
NCT01012323
Treatments Being Tested
NewGam (current working title for a new IGIV formulation) is a newly develo...
Status
Terminated
Location
Multiple Locations
Start Date
2011-10
Trial ID
NCT01225276
Treatments Being Tested
Patients with mild cognitive impairment (MCI) are a group recognized at bei...
Status
Completed
Location
Sutter Neuroscience Medical Group
Start Date
2011-01-01
Trial ID
NCT01300728
Treatments Being Tested